Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
393.00
-9.00 (-2.24%)
At close: May 16, 2025, 4:00 PM
405.02
+12.01 (3.06%)
After-hours: May 16, 2025, 7:14 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $5.11 billion as of May 16, 2025. Its market cap has increased by 10,068.18% in one year.
Market Cap
5.11B
Enterprise Value
5.11B
1-Year Change
10,068.18%
Ranking
Category
Stock Price
$393.00
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $5.11B, an increase of 4,158.17%. That is a compound annual growth rate of 165.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 5.11B | 7,855.47% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |